Cargando…
SERS characterization of colorectal cancer cell surface markers upon anti‐EGFR treatment
Colorectal cancer (CRC) is the third most diagnosed and the second lethal cancer worldwide. Approximately 30–50% of CRC are driven by mutations in the KRAS oncogene, which is a strong negative predictor for response to anti‐epidermal growth factor receptor (anti‐EGFR) therapy. Examining the phenotyp...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190927/ https://www.ncbi.nlm.nih.gov/pubmed/37323700 http://dx.doi.org/10.1002/EXP.20210176 |